source
- FDA lifts hold on Aardvark Therapeutics' ARD-101 after safety study shows no cardiac eventsFDA has lifted the clinical hold on Aardvark Therapeutics' ARD-101 after the company completed an additional safety study. The new data showed no cardiac events, addressing the concerns that prompt…
- New Medicare rules could restrict pain medication access for many patients, doctor warnsA recent Medicare policy proposal would tighten coverage criteria for certain pain‑relief treatments, potentially limiting their availability to patients who rely on them for daily functioning. Ph…